Company News

CellCeuticals Acquired by Histogen

Says will bring new innovation via unique regenerative medicine technology.

Author Image

By: Christine Esposito

Editor-in-Chief

Histogen Aesthetics, a subsidiary of regenerative medicine company Histogen, Inc., has acquired the CellCeuticals Biomedical Skin Treatments line of skin care products.   Histogen Aesthetics said it will continue sales of the 11 existing CellCeuticals Biomedical Skin Treatments skin care products, while bringing new innovation to the line through the addition of a unique regenerative medicine technology, working to improve skin aging at a cellular level.   “We have long admired the science, clin...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters